- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2013
- Public Summary Document (PSD) November 2013 PBAC Meeting - PDF
Denosumab – November 2013
Denosumab, solution for injection, 120 mg in 1,7 mL, Xgeva®
Last updated
8 November 2023